MedTrace Logo

Clinical and Radiographic Evaluation of NIPSA Versus M-MIST in Treatment of Intra-osseous Defects

NCT04149834 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-11-04

No results posted yet for this study

Summary

The aim: Clinical and Radiographic Evaluation for intra-osseous defects in stage III periodontitis using NIPSA versus M-MIST Steps in short Pre-surgical therapy

• Before surgical intervention, each patient will be given careful instructions on proper oral hygiene measures.

Surgical Procedures:

* Group B (Control): Patients will receive Modified Minimally Invasive Surgical technique (M-MIST) Group A (Test): Patients will receive Non-Incised Papilla Surgical Approach (NIPSA) Postoperative medication
* Administration of amoxicillin (500 mg tabs) T.I.D for 7 days and Metronidazole (500 mg tabs) T.I.D for 7 days
* Rinsing with Chlorhexidine 0.12% (B.I.D for 14 days).
* Ibuprofen 600 mg tabs once every 8h could be administrated in case of unbearable pain
* Follow up period: after 8 weeks/ after surgery by 1 week- 1 month- 3 months- 6 months- 1 year

Conditions

  • Periodontitis, Adult

Interventions

PROCEDURE

Group A (Test): Patients will receive NIPSA

patients received Non- incised papilla surgical approache

PROCEDURE

Group B (Control): Patients will receive M-MIST

patients received Modified Minimally Invasive Surgical Technique

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-12-01
Completion
2022-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04149834 on ClinicalTrials.gov